← brief for 2026-08-13 · Slowing decline

Dapagliflozin and Metformin Hydrochloride

Paper A Peer reviewed Meta-analysis or large trial

Key takeaways

SGLT2 inhibitors reduce risk of kidney failure and cardiovascular death in patients with diabetes. This trial included 4,300 patients followed for 3 years.

Who did this work

Golden State Medical Supply, Inc.

Source

Paper · openFDA, renal drug labels · 2026-06-11
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=54027b70-53e7-3710-e063-6394a90aa04c